Condition: Attention Deficit Hyperactivity Disorder (ADHD) · Autism Spectrum Disorder (ASD) · Sponsor: Texas Tech University Health Sciences Center
This pilot study will test whether combining L-theanine and paraxanthine improves sustained attention, inhibitory control, and overall cognition in adults with ADHD and ASD. Two parallel randomized, single-blinded, repeated-measures crossover trials will be conducted. Participants will complete neuropsychological testing, fMRI scanning, and self-report measures following administration of the L-theanine-paraxanthine combination compared to placebo.
This description comes directly from the study's public registry record.
Chathurika S Dhanasekara, MD, PhD · 806-743-2378 · samudani.dhanasekara@ttuhsc.edu
Chanaka N Kahathuduwa, MD, PhD · 806-412-9974 · chanaka.kahathuduwa@ttuhsc.edu
Always discuss trial participation with your own doctor first.
| Texas Tech University | Lubbock, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07189442